Raymond James Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $133
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowered the price target from $160 to $133.
November 09, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Raymond James has maintained an 'Outperform' rating on Zimmer Biomet Holdings but lowered the price target from $160 to $133.
The news is directly related to Zimmer Biomet Holdings. While the 'Outperform' rating is positive, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100